Topic Metabolic syndrome
STATE OF THE ART PAPER
Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease: could the combinations of an old friend with new players yield better outcomes?
Arch Med Sci Atheroscler Dis 2025;10(1):1-15
CLINICAL RESEARCH
Acute myocardial infarction among teenagers in the United States between 2016 and 2020: a retrospective analysis from the National Inpatient Sample
Kamleshun Ramphul, Shruti Aggarwal, Renuka Verma, Petras Lohana, Shaheen Sombans, Yogeshwaree Ramphul, Stephanie Gonzalez Mejias, Deepak Kumar, Nana Amma Kwansa, Prince Kwabla Pekyi-Boateng
Arch Med Sci Atheroscler Dis 2023;8(1):177-181
CLINICAL RESEARCH
The relationship between nutritional facts and temperament of selected Iranians’ frequent food items: a summative content analysis study
Mohsen Zakerian, Fatemeh Roudi, Fatemeh Mahjoub, Tannaz Jamialahmadi, Amirhossein Sahebkar, Malihe Motavasselian
Arch Med Sci Atheroscler Dis 2023;8(1):100-111
STATE OF THE ART PAPER
GLP-1 receptor agonists, SGLT-2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy?
Arch Med Sci Atheroscler Dis 2023;8(1):19-34
STATE OF THE ART PAPER
Empagliflozin therapy and insulin resistance-associated disorders: effects and promises beyond a diabetic state
Arch Med Sci Atheroscler Dis 2021;6(1):57-78
STATE OF THE ART PAPER
Research progress of typical flavonoids in improving insulin resistance
Arch Med Sci Atheroscler Dis 2020;5(1):335-342
CLINICAL RESEARCH
Evaluation of serum endocan levels in relation to epicardial fat tissue thickness in metabolic syndrome patients
Arch Med Sci Atheroscler Dis 2020;5(1):290-296
CLINICAL RESEARCH
Comparison of clinical characteristics between lean and obese nonalcoholic fatty liver disease in the northeast Chinese population
Arch Med Sci Atheroscler Dis 2019;4(1):191-195
CLINICAL RESEARCH
Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?
Aleksandr B. Shek, Rano B. Alieva, Ravshanbek D. Kurbanov, Shavkat U. Hoshimov, Ulugbek I. Nizamov, Adolat V. Ziyaeva
Arch Med Sci Atheroscler Dis 2019;4(1):144-150
LETTER TO THE EDITOR
Sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear?
Arch Med Sci Atheroscler Dis 2019;4(1):13-15
CLINICAL RESEARCH
Outcomes of in-hospital treatment of cardiac patients who survived cardiac arrest and experienced coronary angiography
Arch Med Sci Atheroscler Dis 2018;3(1):1-7
CLINICAL RESEARCH
Metabolic syndrome may be an important comorbidity in patients with seborrheic dermatitis
Arch Med Sci Atheroscler Dis 2016;1(1):158-161
CLINICAL RESEARCH
Metabolic syndrome severity score: range and associations with cardiovascular risk factors
Borislav D. Dimitrov, Karamfil M. Bahchevanov, Penka A. Atanassova, Mitko D. Mitkov, Radka I. Massaldjieva, Kostadin A. Chompalov, Georgi K. Hadzhipetrov
Arch Med Sci Atheroscler Dis 2016;1(1):90-97
LETTER TO THE EDITOR
Acute portal vein thrombosis secondary to hyperhomocysteinemia with folic acid deficiency and methyl tetrahydrofolate reductase mutation: a case report and literature review
Arch Med Sci Atheroscler Dis 2016;1(1):1-5
| ISSN: | 2451-0629 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
